|
PHI-27 (rat)
|
|
96849-38-6
|
|
PHI-27 (porcine)
|
|
80458-29-3
|
|
Prepro VIP (156-170) (human)
|
|
107902-86-3
|
|
Biotinyl-VIP (human, mouse, rat) trifluoroacetate salt
|
|
1815618-13-3
|
|
PHM-27 (human) trifluoroacetate salt
|
|
87403-73-4
|
|
(Ala11·22·2)-VIP (human, mouse, rat) trifluoroacetate salt
|
|
291524-04-4
|
|
(Gly106)-Cytochrome C (92-107) (Manduca sexta)
|
|
213260-63-0
|
|
Abz-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH trifluoroacetate salt
|
|
290362-09-3
|
|
Abz-Ser-Pro-3-nitro-Tyr-OH
|
|
553644-01-2
|
|
4-Abz-Gly-Pro-D-Leu-D-Ala-NHOH trifluoroacetate salt
|
|
124168-73-6
|
|
H-Phe-Phe-OH
|
|
2577-40-4
|
|
Xenin 25
|
|
144092-28-4
|
|
(β-Asp3)-VIP (human, bovine, porcine, rat)
|
|
|
|
VIP (6-28) (human, mouse, rat) trifluoroacetate salt
|
|
69698-54-0
|
|
WWamide-2
|
|
149636-88-4
|
|
VIP Receptor-Binding Inhibitor L-8-K trifluoroacetate salt
|
|
120550-85-8
|
|
VIP (4-28) (human, mouse, rat) trifluoroacetate salt
|
|
64326-02-9
|
|
(Cys(Acm)33)-Endostatin (6-49) (human)
|
|
|
|
VIP (3-28) (human, mouse, rat) trifluoroacetate salt
|
|
115444-33-2
|
|
(D-Phe2)-VIP (human, mouse, rat)
|
|
104051-15-2
|
|
Xenopsin-Related Peptide 1 (XP-1)
|
|
117442-28-1
|
|
Ac-Ala-Ala-OMe
|
|
30802-26-7
|
|
6-(7-Nitro-benzo[2,1,3]oxadiazol-4-ylamino)-hexanoyl-Arg-Pro-Lys-Pro-Leu-Ala-Nva-Trp-Lys((7-dimethylaminocoumarin-4-yl)-acetyl)-NH trifluoroacetate salt
|
|
945414-97-1
|
|
(H-Cys-Gly-OH) (Disulfide bond)
|
|
7729-20-6
|
|
(H-Cys-Tyr-OH) (Disulfide bond)
|
|
7369-94-0
|
|
RF9 trifluoroacetate salt
|
|
876310-60-0
|
|
Ac-Ala-Ala-Ala-OMe
|
|
26910-17-8
|
|
Ac-Ala-Ala-Ala-pNA
|
|
40817-33-2
|
|
H-D-Ala-D-Ala-D-Ala-D-Ala-D-Ala-D-Ala-OH
|
|
286842-36-2
|
|
Abz-Gly-Ala-Ala-Pro-Phe-3-nitro-Tyr-Asp-OH trifluoroacetate salt
|
|
142689-23-4
|
|
(H-Cys-Ala-OH) (Disulfide bond)
|
|
20898-21-9
|
|
(Cys935)-Focal Adhesion Kinase 1 (921-935) amide (human)
|
|
|
|
(Deamino-Cys1,Leu,Lys)-Vasopressin trifluoroacetate salt
|
|
42061-33-6
|
|
(d(CH2)51,Tyr(Et)2,Val4,Arg8)-Vasopressin
|
|
77453-01-1
|
|
(d(CH)1,Tyr(Et)2,Val,Arg,des-Gly)-Vasopressin trifluoroacetate salt
|
|
90332-81-3
|
|
(Arg)-Vasotocin acetate salt
|
|
113-80-4
|
|
(d(CH)1,Tyr(Et)2,Val,Arg,des-Gly-NH)-Vasopressin
|
|
110567-67-4
|
|
(d(CH)1,Tyr(Me)2,Arg)-Vasopressin trifluoroacetate salt
|
|
73168-24-8
|
|
(d(CH)1,D-Tyr(Et)2,Val,Arg,des-Gly)-Vasopressin
|
|
90332-82-4
|
|
(Deamino-Cys1,Lys)-Vasopressin trifluoroacetate salt
|
|
2989-84-6
|
|
VIP sulfoxide (human, mouse, rat) trifluoroacetate salt
|
|
95050-90-1
|
|
H-His-Leu-Pro-Pro-Pro-Val-His-Leu-Pro-Pro-Pro-Val-OH
|
|
154244-49-2
|
|
H-D-ALA-GLY-OH
|
|
3997-90-8
|
|
(d(CH)1,D-Ile2,Ile,Arg,Ala-NH)-Vasopressin
|
|
114455-29-7
|
|
(d(CH)1,Tyr(Me)2,Thr,Orn,des-Gly-NH)-Vasotocin trifluoroacetate salt
|
|
115499-13-3
|
|
Abz-Ala-Phe-Ala-Phe-Asp-Val-Phe-3-nitro-Tyr-Asp-OH trifluoroacetate salt
|
|
143147-74-4
|
|
(H-Cys-Leu-OH) (Disulfide bond)
|
|
21141-85-5
|
|
(H-Cys-Val-OH) (Disulfide bond)
|
|
21141-84-4
|
|
(1-Adamantaneacetyl1,D-Tyr(Et)2,Val,Abu, Arg·)-Vasopressin
|
|
112465-00-6
|
|
(4-(4-Azidophenyl)butyryl1,D-Tyr(Me)2,Arg6,Arg8,Tyr-NH29)-Vasopressin
|
|
|
|
(H-Cys-Phe-OH) (Disulfide bond)
|
|
62130-80-7
|
|
Ac-Ala-Ala-Ala-Ala-OMe
|
|
30802-29-0
|
|
(Arg)-Vasopressin trifluoroacetate salt
|
|
113-79-1
|
|
Biotinyl-(Arg)-Vasopressin trifluoroacetate salt
|
|
126703-17-1
|
|
Endothelin-2 (mouse, rat)
|
|
138863-63-5
|
|
(Gln3)-Connexin 37 (51-58) (human, mouse, rat)
|
|
155893-22-4
|
|
Ac-Ala-Ala-Phe-OMe
|
|
50395-42-1
|
|
(Cys8)-pTH (1-8) (human)
|
|
844499-32-7
|
|
H-His-Leu-Pro-Pro-Pro-Val-OH
|
|
121305-29-1
|
|
VIP (guinea pig) trifluoroacetate salt
|
|
96886-24-7
|
|
(N-Me-Lys3)-Xenopsin (3-8)
|
|
|
|
(p-Chloro-D-Phe,Leu1)-VIP (human, mouse, rat) trifluoroacetate salt
|
|
102805-45-8
|
|
Xenopsin (XP)
|
|
51827-01-1
|
|
(Pyr16)-VIP (16-28) (chicken)
|
|
73073-47-9
|
|
Ac-Ala-Ala-OH
|
|
19245-87-5
|
|
Ac-Ala-Ala-Ala-Ala-OH
|
|
15483-58-6
|
|
Ac-Ala-Ala-Pro-Ala-AMC
|
|
62037-45-0
|
|
Ac-Phe-Tyr-OH
|
|
2365-53-9
|
|
4-Biphenylac-Cys(Me)-D-Arg-Phe-(2-phenylethyl)amide
|
|
478164-48-6
|
|
(H-Gly-Cys-OH) (Disulfide bond)
|
|
26798-52-7
|
|
Prepro VIP (81-122) (human)
|
|
111366-38-2
|
|
(Lys8)-Vasotocin (free acid)
|
|
|
|
Prepro VIP (111-122) (human)
|
|
123025-94-5
|
|
Abz-Gly-Ile-Val-Arg-Ala-Lys(Dnp)-OH
|
|
827044-38-2
|
|
(d(CH2)51,D-Tyr(Me)2,Val4,Arg8)-Vasopressin
|
|
|
|
VIP Antagonist
|
|
125093-93-8
|
|
Xenopsin-Related Peptide 2 (XP-2) trifluoroacetate salt
|
|
117442-29-2
|
|
(d(CH)1,D-Phe2,Ile,Ala-NH)-Vasopressin
|
|
99835-78-6
|
|
Ac-Ala-Ala-Ala-OH
|
|
19245-85-3
|
|
Abz-Phe-Arg-Lys(Dnp)-Pro-OH hydrochloride salt
|
|
500799-61-1
|
|
(Deamino-Cys1,β-cyclohexyl-Ala,Arg)-Vasopressin trifluoroacetate salt
|
|
500170-27-4
|
|
(H-Glu(Cys-βNA)-OH)2
|
|
201990-68-3
|
|
Abz-Ala-Gly-Leu-Ala-p-nitrobenzylamide
|
|
100307-95-7
|
|
MAGE-1 Antigen (161-169) (human) acetate salt
|
|
144449-86-5
|
|
H-Glu-Glu-Lys-Leu-Ile-Val-Val-Ala-Phe-OH
|
|
188818-21-5
|
|
Abz-Glu-Ile-Phe-Val-Phe-Lys-Gln-ethylenediamine-Dnp
|
|
848491-08-7
|
|
H-Ala-Ala-Ala-Ala-Glu-Glu-Glu-Glu-Glu-OH
|
|
|
|
(Arg,des-Gly-NH)-Vasopressin
|
|
37552-33-3
|
|
Abz-Ala-Phe-Arg-Phe-Ser-Gln-EDDnp trifluoroacetate salt
|
|
1926163-28-1
|
|
Urotensin II-Related Peptide (human, mouse, rat) trifluoroacetate salt
|
|
342878-90-4
|
|
(Arg)-Vasopressin (free acid) trifluoroacetate salt
|
|
25255-33-8
|
|
WWamide-3
|
|
149636-89-5
|
|
(Pyr1)-VIP (16-28) (human, mouse, rat)
|
|
134907-86-1
|
|
VIP (10-28) (human, bovine, porcine, rat)
|
|
69856-17-3
|
|
(d(CH)1,Tyr(Me)2,Thr,Orn,Tyr-NH)-Vasotocin trifluoroacetate salt
|
|
114056-26-7
|
|
Abz-Gln-Val-Val-Ala-Gly-Ala-EDDnp trifluoroacetate salt
|
|
152390-52-8
|
|
(d(CH)1,D-Ile2,Ile,Arg)-Vasopressin
|
|
88686-53-7
|
|
(Deamino-Cys1,D-Orn)-Vasopressin
|
|
60498-04-6
|
|
(3-(4-Azidophenyl)propionyl1,D-Tyr(Me)2,Arg,Arg,Tyr-NH)-Vasopressin trifluoroacetate salt
|
|
157702-46-0
|
|
WWamide-1
|
|
149665-72-5
|